Health Technology/clinical-trials

Landmark Prospective Trial Opens: AI-Based Early Warning System for Cancer Metastasis Detection — What Oncologists Need to Know

247 Health News Editorial

·

14 June 2026

·

3 min read

·clinical-trials

A landmark 10,000-patient prospective trial is validating AI-based early warning systems for cancer metastasis detection. This could transform oncology surveillance from reactive treatment to proactive risk prediction.

Originally reported by ClinicalTrials.gov

References

  1. 1.Sun Yat-Sen Memorial Hospital. (2024). Artificial Intelligence-Based Early Warning for Distant Metastasis in Malignant Tumors. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07616011
  2. 2.Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 233-254. https://doi.org/10.3322/caac.21763
  3. 3.Chaffer, C. L., & Weinberg, R. A. (2011). A perspective on cancer cell metastasis. Science, 331(6024), 1559-1564. https://doi.org/10.1126/science.1203543
  4. 4.Hosny, A., Parmar, C., Quackenbush, J., Schwartz, L. H., & Aerts, H. J. (2018). Artificial intelligence in radiology. Nature Reviews Cancer, 18(8), 500-510. https://doi.org/10.1038/s41568-018-0016-5
  5. 5.Liu, X., Faes, L., Kale, A. U., Wagner, S. K., Fu, D. J., Bruynseels, A., ... & Denniston, A. K. (2019). A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging. The Lancet Digital Health, 1(6), e271-e297. https://doi.org/10.1016/S2589-7500(19)30123-2
  6. 6.Steeg, P. S. (2016). Targeting metastasis. Nature Reviews Cancer, 16(4), 201-218. https://doi.org/10.1038/nrc.2016.25
  7. 7.Howlader, N., Noone, A. M., Krapcho, M., Miller, D., Brest, A., Yu, M., ... & Cronin, K. A. (2023). SEER Cancer Statistics Review, 1975-2020. National Cancer Institute. https://seer.cancer.gov/csr/1975_2020/
  8. 8.Gerlinger, M., Rowan, A. J., Horswell, S., Math, M., Larkin, J., Endesfelder, D., ... & Swanton, C. (2012). Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New England Journal of Medicine, 366(10), 883-892. https://doi.org/10.1056/NEJMoa1113205
  9. 9.Therapeutic Goods Administration. (2023). Software as Medical Device: Guidance for manufacturers. Australian Government Department of Health. https://www.tga.gov.au/resources/resource/guidance/software-medical-device-guidance-manufacturers
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service